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 Patient: Female, 40
 Final Diagnosis: Gout
 Symptoms: Joint pain
 Medication: —
 Clinical Procedure: Dual energy Computed tomography 
 Specialty: Rheumatology
 Objective: Rare co-existance of disease or pathology
 Background: Gout is characterized by deposition of uric acid crystals (monosodium urate) in tissues and fluids. This can 
cause acute inflammatory arthritis. The 2015 ACR/EULAR criteria for the diagnosis of gout include dual ener-
gy computed tomography (DECT)-demonstrated monosodium urate crystals as a new criterion. DECT is a spec-
tral decomposition that permits recognition of different types of tissues based on their characteristic energy-
dependent photon attenuation. A positive scan is defined as the presence of urate at articular or periarticular 
sites.
 Case Report: We describe a 51-year-old woman known to have anorexia nervosa. During our clinical examination, we detect-
ed plenty of tophi on both hands, but no swollen joints. The diagnosis of gout was made by visualizing crys-
tals in a biopsy from a tophus. The first line of treatment was allopurinol, the second line was rasburicase, and 
the current treatment is febuxostat 80 mg/day, allopurinol 300 mg twice a day, and colchicine 0.5 mg twice a 
day. The patient has unchanged arthralgia and the size and number of tophi remain the same as before treat-
ment in spite of active treatment for 3 years. Previously the patient had problems with adherence, but now she 
claims that she follows the proposed treatment. The last plasma urate (P-urate) was 0.57 mmol/L. Following 
two years of treatment, DECT of hands visualized monosodium urate crystal deposits in the tophi, as seen on 
the clinical photos, but also crystals in relation to the tendons and soft tissue.
 Conclusions: DECT is an imaging modality useful to assess urate crystal deposits at diagnosis of gout and could be consid-
ered during treatment evaluation. Lack of adherence to treatment should be considered when P-urate values 
vary significantly and when DECT scans over years persistently visualize monosodium urate crystals.
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Background
Gout is the most common inflammatory arthritis among men 
and postmenopausal women with a prevalence between 2% 
and 4% [1]. Women represent 5–20% of patients with gout [2]. 
The prevalence of hyperuricemia (a precondition of gout) is 
more than 21% [3]. Gout is characterized by deposition of uric 
acid crystals (monosodium urate) in tissues and synovial flu-
ids. This can cause an acute inflammatory arthritis character-
ized by sudden, severe attacks of pain, redness, and inflamma-
tion in joints. Gout initially affects only one joint at a time, but 
over time, it can become chronic and could affect several joints. 
Gout is one of the most painful forms of arthritis and is the 
cause of disability for many [4,5]. Tophaceous gout is a termi-
nal manifestation of gout [6]. Tophaceous gout in a patient with 
anorexia nervosa is very seldom described in the literature [2].
Microscopic examination by polarized compensated light mi-
croscopy of the joint fluid or of tophi is the gold standard for 
verifying the diagnosis [7]. The 2015 ACR/EULAR criteria for the 
diagnosis of gout include dual energy computed tomography 
(DECT)-demonstrated monosodium urate crystals as a criterion. 
If monosodium urate crystals are not found in synovial fluids or 
tophi, the diagnosis of gout can be based on the entry criteri-
on followed by a scoring system. The entry criterion is at least 
one characteristic attack of gout in a peripheral joint or bursa as 
mentioned above. The scoring system includes three major do-
mains: clinical features, laboratory measurements, and imaging 
evidence. A score ³8 is diagnostic for gout. Detection of monoso-
dium urate crystals with DECT yields 4 points. Four extra points 
can be added if gout-related joint damage can be visualized [5,7].
DECT has spurred interest as a noninvasive examination for 
detection of, for example, urinary stone composition, hepat-
ic fatty infiltration, and several cancers [8–10]. A DECT scan-
ner uses simultaneously a regular X-ray and a second X-ray 
with lower energy, typically a setting of 80 kVp and 140 kVp, 
which gives more possibilities than standard computed to-
mography (CT) [5,11]. The greatest benefit of DECT is spectral 
decomposition that permits recognition of different types of 
tissues, based on their characteristic energy-dependent pho-
ton attenuation [5,8–10].
In previous studies, DECT imaging has shown to be a useful 
noninvasive tool to confirm the presence of monosodium urate 
crystals within joints, tophi, and tendons [3]. A positive scan is 
defined as the presence of urate at articular or periarticular sites.
Case Report
The patient is a 51-year-old Caucasian woman known to 
have had anorexia nervosa since her teenage years [12]. For 
several years, she was followed at the Department of Nutrition 
Disorders. Four years before our first contact with the patient, 
a tentative diagnosis of gout was made by her private practi-
tioner. He visualized needle-shaped crystals in a biopsy from 
a skin lesion at a toe tip. Before admission, she was treat-
ed with allopurinol in varying doses, but probably with vary-
ing adherence.
She was sent to the hospital´s diagnostic unit because of 
weight loss, which was found to be associated with her an-
orexia (down to 38.5 kg), and arthralgia. Malignant disease 
was ruled out, and the patient was referred to the Department 
of Rheumatology.
Clinical examination demonstrated plenty of tophi on both 
hands (Figure 1), but no swollen joints. The patient could elab-
orate on her medical history and tell that small hard nodules 
localized in the skin of the fingers often broke and subsequent-
ly flowed with toothpaste-like material.
Plasma urate (P-urate) was normal, 0.37 mmol/L, at first vis-
it (Figure 2). Estimated glomerular filtration rate (GFR) was 
60 mL/min/1.73 m2, and C-reactive protein (CRP) was <10 mg/L. 
The patient was rheumatoid factor and cyclic citrullinat-
ed peptide antibody negative. Biochemistry was as follows: 
serum urate varied considerably during the following three 
years from 0.03 to 0.59 (0.16-0.40), as well as albumin from 
16 to 33 g/L (36–48 g/L), potassium from 1.8 to 5.6 mmol/L 
(3.5–4.4 mmol/L), and magnesium from 0.49 to 0.71 mmol/L 
(0.71–0.94 mmol/L). Microscopic examination of material as-
pirated from a tophus confirmed the gout diagnosis.
X-ray of the patient’s feet showed considerable arthritis; hands 
were normal without arthritis.
Figure 1.  Clinical photos of the patient’s hands after two years 
of treatment.
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CT scan of thorax and abdomen showed no signs of malig-
nant disease, cholecystectomia facta, pancreatitis sequela, or 
arteriosclerosis aortae.
Dual-energy x-ray absorptiometry (DEXA) scan results were as 
follows: T score Columna –4.2, collum femoris –3.7. A DECT HD 
750 General Electric CT scanner was used to perform an initial 
scan of the hands and feet, and after 1 and 2 years of treat-
ment visualized nonsignificant changes in the amount of mono-
sodium urate crystal deposits in the tophi seen on the clinical 
photos, but also crystals in relation to the tendons and soft 
tissue of the hands. The localization of the color coding corre-
sponded to the localization of the tophis seen on the clinical 
picture. By measuring the DECT z-values in different crystals, 
we obtained a mean value of 7.31±0.21. In comparison, the 
calculated z-value for the urate crystals was 6.95. Comparing 
the results from the DECT scans, we saw no obvious differ-
ences before and after two years of treatment (Figures 3, 4).
The patient restarted treatment with allopurinol without suffi-
cient effect; P-urate increased to 0.48 mmol/L. The second line 
of treatment was rasburicase, a recombinant urate oxidase. 
Figure 3. DECT scan after two years of treatment. Figure 4. DECT scan after two years of treatment.
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Figure 2.  Plasma urate changes over time with different treatments. Second-line treatment with rasburicase from February until May 
2013. Treatment with allopurinol and colchicine from May until October 2014. Third-line treatment with febuxostat since 
October 2014.
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The patient was given rasburicase 7.5 mg intravenously, first 
with a dose a day for 2 days and then once a week. She was 
treated with rasburicase for 3 months.
The patient developed intolerance to rasburicase, and the treat-
ment was discontinued. After the first two treatments with ras-
buricase, the P-urate fell to 0.03 mmol/L, but after one month 
it was back to 0.48 mmol/L.
A second attempt was made to treat the patient with allopu-
rinol 500 mg/day and colchicine 0.5 mg/day. The treatment 
was still not sufficient to keep the P-urate at the target level 
of 0.30 mmol/L and to prevent the arthralgia.
Since October 2014, the patient has been treated with febux-
ostat 80 mg/day, a xanthine oxidase inhibiter, combined with 
allopurinol 300 mg twice a day and colchicine 0.5 mg twice a 
day. Blood samples initially showed a decline in P-urate, the 
lowest level down to 0.27 mmol/L, but lately levels have in-
creased to more than 0.57 mmol/L
The patient complains that after three years of treatment her 
arthralgia is unchanged. It is estimated that the numbers and 
sizes of tophi are unchanged as well. From older files we no-
ticed that the patient had problems with adherence, but she 
claims that she now follows the proposed treatment.
Discussion
Treatment of patients with anorexia nervosa can be very dif-
ficult, as this case illustrates, and adherence might be prob-
lematic [13]. P-urate was normal initially in our patient. DECT 
was used to visualize monosodium urate crystals in soft tis-
sues, joints, and tendons. The relative importance of DECT is 
yet unknown, but it can differentiate between pyrophosphate 
crystals and monosodium urate crystals [14], and it is a use-
ful tool in evaluating diagnosis and the extent of diseases in 
patients who present with arthralgia and/or arthritis symp-
toms. DECT can thereby be an especially important tool in the 
detection of subclinical disease [5]. To our knowledge, this is 
the first time monosodium urate crystals have been visual-
ized by DECT in a patient diagnosed with anorexia nervosa.
In our case DECT was valuable in the detection of monosodi-
um urate deposition. At this point, the greatest challenge re-
garding DECT and its use in the diagnosis and monitoring of 
gout treatment is the fact that DECT is very user dependent. 
The patient in this case study did not have arthritis but ar-
thralgia, and for the purpose of considering differential diag-
noses in this patient, DECT was valuable [14].
For differential diagnosis purposes, malignancy had to be ruled 
out, especially because of simultaneous weight loss, as in this 
case. Other differential diagnoses could be small cutaneous 
abscesses, tendinitis, or pyrophosphate arthritis.
The z-values in our visual tophi were comparable to urate crys-
tal composition. Despite the absence of gout attack/flares and 
no improvement in arthralgia, the diagnosis of gout was sup-
ported by DECT.
As concluded in an article by Hu et al. [11], the results of a DECT 
scan should be interpreted carefully because of false findings. 
Predefined setting in DECT increases the risk for false- posi-
tive and false-negative results. More studies have to be made 
for better determination of the parameters.
Bongartz et al. [15] concluded that DECT has a high specific-
ity and sensitivity for diagnosis of gout, particularly when it 
is not possible to detect needle-shaped crystals with micros-
copy and thereby confirm the diagnosis. However, they found 
reduced sensitivity for early-onset gout.
In evaluating the treatment response of tophaceous gout, we 
suggest that besides counting the number of tophi and re-
peating the DECT scan, clinicians use the newly introduced 
patient-reported outcome measure of tophus burden: The 
Tophus Impact Questionnaire [16].
Conclusions
DECT is an imaging modality useful to assess urate crystal 
deposits at diagnosis of gout and could have a place during 
treatment evaluation.
Lack of adherence to treatment should be considered when 
P-urate values vary significantly and monosodium urate crys-
tals are visualized by DECT scan, especially if the scans do not 
change significantly after years of treatment. Getting a suf-
ficient treatment response in patients with anorexia nervosa 
and gout might be very difficult.
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